Stroke-injured mice displayed a significant motor deficit on the grid walking task at PSD4 prior to treatment with Cre or Neurod1 (p = 0.003, p = 0.002, respectively) (Figure 1i). This evidence concerns the gene NEUROD1 and stroke disorder.